Universities that aim to raise money for research by selling access to their biobanks to private companies should tell patients, a new survey shows. In fact, saying what the money will be used for will likely encourage patients to donate their samples.
from Top Health News -- ScienceDaily https://ift.tt/2Pm8ks1
Subscribe to:
Post Comments (Atom)
Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO
However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...
-
The IT major further said the Ebit margin for the current quarter is expected to be between 20.5-21 per cent from Home Page https://ift.tt...
-
Here's a look at some of the companies whose shares are expected to trade actively in Friday's session - from Home Page http://bit...
-
New heat-harnessing 'solar' cells that reflect 99% of the energy they can't convert to electricity could help bring down the pri...
No comments:
Post a Comment